Multi-drug resistant TB should be treated as a public health emergency

Experts gathered at a conference in London last week called for urgent action to tackle the global problem of multi-drug resistant tuberculosis.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

LONDON Experts gathered in London last week to call for urgent action to tackle the global problem of multi-drug resistant tuberculosis. Resistance to the commonly used anti-TB drugs is increasing rapidly in many countries of the world, particularly the former Soviet Union.

Mario Raviglione, co-ordinator of TB Strategy and Operations at the World Health Organisation said: "The situation in countries such as Estonia should be treated as a public health emergency on a par with an Ebola outbreak. In general about 2–3% of TB is multi-drug resistant but this rises to 14% of new cases in Estonia."

The meeting, 'TB drug resistance: from molecules to macro-economics', held at the Royal Society of Medicine, gathered together for the first time specialists in many different fields in order to uncover the extent of drug-resistant TB and discuss strategies to deal with it.

Tuberculosis kills two million people each year and the number ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jacqui Wise

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo